Ksolves India Limited Grants 4,000 Employee Stock Options Under Scheme II, 2024
Ksolves India Limited announced the grant of 4,000 Employee Stock Options under its new ESOP Scheme-II, 2024, approved by the Board on April 30, 2026. Each option converts to one equity share of Rs. 5.00 face value at 20% discount to market price, with a minimum one-year vesting period and three-year exercise window from vesting date.

*this image is generated using AI for illustrative purposes only.
Ksolves India Limited's Board of Directors convened on April 30, 2026, and approved the grant of 4,000 Employee Stock Options (ESOPs) under the Ksolves Employee Stock Option Scheme-II, 2024. The disclosure was made to the National Stock Exchange of India and the Bombay Stock Exchange in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Details of the ESOP Grant
The scheme involves the grant of 4,000 options to eligible employees, with each option convertible into one equity share of the company. The equity shares carry a face value of Rs. 5.00 each. The exercise price for these options has been set at a 20% discount to the market price of the company's shares as specified under the scheme terms.
Scheme Governance and Vesting Terms
The Ksolves Employee Stock Option Scheme-II is administered by the Nomination and Remuneration Committee. The grant of options is based on eligibility criteria outlined in the scheme document. There is a mandatory minimum period of one year between the grant of options and their vesting. Once vested, options entitle holders to acquire an equal number of equity shares upon payment of the exercise price and applicable taxes in accordance with the scheme's terms and conditions.
Exercise Period and Share Issuance
All vested options must be exercised, either in full or in part, within three years from the date of respective vesting. Upon exercise of all 4,000 options, the company will issue 4,000 new equity shares. The scheme is compliant with SEBI (SBE B & SE) Regulations, 2021.
Summary of ESOP Grant Terms
| Particulars: | Details |
|---|---|
| Name of Scheme: | Ksolves Employee Stock Option Scheme II |
| Options Granted: | 4000 options |
| Effective Grant Date: | April 30, 2026 |
| Shares Covered: | 4000 Equity Shares of Rs. 5.00 each |
| Pricing Formula: | 20% discount to Market Price |
| Minimum Vesting Period: | 1 year from grant date |
| Exercise Period: | Within 3 years from vesting date |
| Scheme Compliance: | SEBI (SBE B & SE) Regulations, 2021 |
Historical Stock Returns for Ksolves
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.02% | -10.90% | +1.83% | -7.47% | -29.89% | +358.05% |
How will the potential dilution from 4,000 new equity shares impact Ksolves' earnings per share and existing shareholder value?
What does this ESOP grant signal about Ksolves' talent retention strategy and expected business growth in the coming years?
Will Ksolves expand this employee stock option program further if the current scheme successfully retains key personnel?


































